Skip to main content

Patient Blood Management in Critically Ill

  • Chapter
  • First Online:
Hematologic Challenges in the Critically Ill

Abstract

Anaemia is much more prevalent than commonly thought and is an independent risk factor for morbidity and mortality. For a long time, transfusion with allogeneic blood components has been considered the only method to correct and reverse anaemia especially in hospitalized and intensive care units (ICU) till the notion that transfusion might represent an additional independent risk factor for morbidity and mortality creating uncertainty among clinicians regarding an appropriate transfusion practice. Patient Blood Management (PBM) evolved from the urgent need for an adequate anaemia management and offers more than 100 measures to optimize patient’s own blood. In general, PBM consist of three pillars: first, a comprehensive anaemia management; second, the minimization of iatrogenic (avoidable) blood loss; and third, the establishment of a rational management of haemotherapy that could include transfusions.

The pathology and physiology of ICU patients are multifactorial due to disease-related and iatrogenic blood loss. Critically ill patients are prone for bleeding due to their primary illness and acquired coagulopathy. Anaemia is extremely common in these patients (60–80%), and after 1 week of ICU stay, approximately 97% of patients are anaemic, and about 39–44% receive at least transfusion of 1 RBC unit. PBM guides the clinician through a timely and evidence-based concept to offer management of anaemia, coagulation and prevention of blood loss at any time during ICU stay and beyond.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Meybohm P, Richards T, Isbister J, Hofmann A, Shander A, Goodnough LT, Munoz M, Gombotz H, Weber CF, Choorapoikayil S, et al. Patient blood management bundles to facilitate implementation. Transfus Med Rev. 2017;31(1):62–71.

    Article  Google Scholar 

  2. Bulger J, Nickel W, Messler J, Goldstein J, O'Callaghan J, Auron M, Gulati M. Choosing wisely in adult hospital medicine: five opportunities for improved healthcare value. J Hosp Med. 2013;8(9):486–92.

    Article  Google Scholar 

  3. Availability, safety and quality of blood products. [http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf].

  4. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. [http://www.who.int/vmnis/indicators/haemoglobin.pdf].

  5. Collaborators GBoDS. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet (London, England). 2015;386(9995):743–800.

    Article  Google Scholar 

  6. Munoz M, Gomez-Ramirez S, Campos A, Ruiz J, Liumbruno GM. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood transfusion = Trasfusione del sangue. 2015;13(3):370–9.

    PubMed  PubMed Central  Google Scholar 

  7. Fowler AJ, Ahmad T, Phull MK, Allard S, Gillies MA, Pearse RM. Meta-analysis of the association between preoperative anaemia and mortality after surgery. Br J Surg. 2015;102(11):1314–24.

    Article  CAS  Google Scholar 

  8. Lasocki S, Krauspe R, von Heymann C, Mezzacasa A, Chainey S, Spahn DR. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study. Eur J Anaesthesiol. 2015;32(3):160–7.

    Article  Google Scholar 

  9. Baron DM, Hochrieser H, Posch M, Metnitz B, Rhodes A, Moreno RP, Pearse RM, Metnitz P. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth. 2014;113(3):416–23.

    Article  CAS  Google Scholar 

  10. Scrascia G, Guida P, Caparrotti SM, Capone G, Contini M, Cassese M, Fanelli V, Martinelli G, Mazzei V, Zaccaria S, et al. Incremental value of anemia in cardiac surgical risk prediction with the European system for cardiac operative risk evaluation (EuroSCORE) II model. Ann Thorac Surg. 2014;98(3):869–75.

    Article  Google Scholar 

  11. Hung M, Besser M, Sharples LD, Nair SK, Klein AA. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia. 2011;66(9):812–8.

    Article  CAS  Google Scholar 

  12. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet (London, England). 2011;378(9800):1396–407.

    Article  Google Scholar 

  13. Sakr Y, Lobo S, Knuepfer S, Esser E, Bauer M, Settmacher U, Barz D, Reinhart K. Anemia and blood transfusion in a surgical intensive care unit. Crit Care. 2010;14(3):R92.

    Article  Google Scholar 

  14. du Cheyron D, Parienti JJ, Fekih-Hassen M, Daubin C, Charbonneau P. Impact of anemia on outcome in critically ill patients with severe acute renal failure. Intensive Care Med. 2005;31(11):1529–36.

    Article  Google Scholar 

  15. von Heymann C, Kaufner L, Sander M, Spies C, Schmidt K, Gombotz H, Wernecke KD, Balzer F. Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery? J Thorac Cardiovasc Surg. 2016;152(5):1412–20.

    Article  Google Scholar 

  16. Khanna R, Harris DA, McDevitt JL, Fessler RG, Carabini LM, Lam SK, Dahdaleh NS, Smith ZA. Impact of Anemia and transfusion on readmission and length of stay after spinal surgery: a single-center study of 1187 operations. Clin Spine Surg. 2016.

    Google Scholar 

  17. Walsh TS, Lee RJ, Maciver CR, Garrioch M, Mackirdy F, Binning AR, Cole S, McClelland DB. Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med. 2006;32(1):100–9.

    Article  Google Scholar 

  18. Westbrook A, Pettila V, Nichol A, Bailey MJ, Syres G, Murray L, Bellomo R, Wood E, Phillips LE, Street A, et al. Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med. 2010;36(7):1138–46.

    Article  CAS  Google Scholar 

  19. Van Remoortel H, De Buck E, Dieltjens T, Pauwels NS, Compernolle V, Vandekerckhove P. Methodologic quality assessment of red blood cell transfusion guidelines and the evidence base of more restrictive transfusion thresholds. Transfusion. 2016;56(2):472–80.

    Article  Google Scholar 

  20. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, Holcomb JB, Illoh O, Kaplan LJ, Katz LM, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med. 2012;157(1):49–58.

    Article  Google Scholar 

  21. Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK, Clough ER, Shore-Lesserson LJ, Goodnough LT, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944–82.

    Article  Google Scholar 

  22. Napolitano LM, Kurek S, Luchette FA, Anderson GL, Bard MR, Bromberg W, Chiu WC, Cipolle MD, Clancy KD, Diebel L, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. J Trauma. 2009;67(6):1439–42.

    Article  Google Scholar 

  23. Rodgers GM 3rd, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, Coccia PF, Djulbegovic B, Gilreath JA, Kraut EH, et al. Cancer- and chemotherapy-induced anemia. J National Comprehensive Cancer Network: JNCCN. 2012;10(5):628–53.

    Article  Google Scholar 

  24. Shander A, Fink A, Javidroozi M, Erhard J, Farmer SL, Corwin H, Goodnough LT, Hofmann A, Isbister J, Ozawa S, et al. Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes. Transfus Med Rev. 2011;25(3):232–46. e253.

    Article  Google Scholar 

  25. Therapies. ASoATFoPBTaA. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies. Anesthesiology. 2006;105(1):198–208.

    Article  Google Scholar 

  26. Gibson BE, Todd A, Roberts I, Pamphilon D, Rodeck C, Bolton-Maggs P, Burbin G, Duguid J, Boulton F, Cohen H, et al. Transfusion guidelines for neonates and older children. Br J Haematol. 2004;124(4):433–53.

    Article  Google Scholar 

  27. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, Allard S, Thomas D, Walsh T. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol. 2013;160(4):445–64.

    Article  CAS  Google Scholar 

  28. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox KA, Hasdai D, Ohman EM, Wallentin L, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598–660.

    Article  CAS  Google Scholar 

  29. Spahn DR, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Gordini G, Stahel PF, Hunt BJ, Komadina R, Neugebauer E, et al. Management of bleeding following major trauma: a European guideline. Crit Care. 2007;11(1):R17.

    Article  Google Scholar 

  30. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228.

    Article  CAS  Google Scholar 

  31. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood transfusion = Trasfusione del sangue. 2011;9(2):189–217.

    PubMed  PubMed Central  Google Scholar 

  32. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period. Blood transfusion = Trasfusione del sangue. 2011;9(3):320–35.

    PubMed  PubMed Central  Google Scholar 

  33. TRANSFUSIEGIDS samengesteld op basis van de CBO Richtlijn Bloedtransfusie. [https://www.nvkc.nl/sites/default/files/17%20Transfusiegids.pdf].

  34. Carson JL, Triulzi DJ, Ness PM. Indications for and adverse effects of red-cell transfusion. N Engl J Med. 2017;377(13):1261–72.

    Article  Google Scholar 

  35. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111(16):2042–9.

    Article  CAS  Google Scholar 

  36. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ (Clinical Research ed). 2015;h1354:350.

    Google Scholar 

  37. Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K, Khanykin B, Gregory AJ, de Medicis E, McGuinness S, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017.

    Google Scholar 

  38. LeRoux P. Haemoglobin management in acute brain injury. Curr Opin Crit Care. 2013;19(2):83–91.

    Article  Google Scholar 

  39. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, Graupera I, Poca M, Alvarez-Urturi C, Gordillo J, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21.

    Article  CAS  Google Scholar 

  40. Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The important role for intravenous Iron in perioperative patient blood Management in Major Abdominal Surgery: a randomized controlled trial. Ann Surg. 2016;264(1):41–6.

    Article  Google Scholar 

  41. Kim YW, Bae JM, Park YK, Yang HK, Yu W, Yook JH, Noh SH, Han M, Ryu KW, Sohn TS, et al. Effect of intravenous ferric Carboxymaltose on hemoglobin response among patients with acute Isovolemic Anemia following gastrectomy: the FAIRY randomized clinical trial. JAMA. 2017;317(20):2097–104.

    Article  CAS  Google Scholar 

  42. Meybohm P, Goehring MH, Choorapoikayil S, Fischer D, Rey J, Herrmann E, Mueller MM, Geisen C, Schmitz-Rixen T, Zacharowski K. Feasibility and efficiency of a preoperative anaemia walk-in clinic: secondary data from a prospective observational trial. Br J Anaesth. 2017;118(4):625–6.

    Article  CAS  Google Scholar 

  43. Quintana-Diaz M, Fabra-Cadenas S, Gomez-Ramirez S, Martinez-Virto A, Garcia-Erce JA, Munoz M. A fast-track anaemia clinic in the emergency department: feasibility and efficacy of intravenous iron administration for treating sub-acute iron deficiency anaemia. Blood transfusion = Trasfusione del sangue. 2016;14(2):126–33.

    PubMed  PubMed Central  Google Scholar 

  44. So-Osman C, Nelissen RG, Koopman-van Gemert AW, Kluyver E, Poll RG, Onstenk R, Van Hilten JA, Jansen-Werkhoven TM, van den Hout WB, Brand R, et al. Patient blood management in elective total hip- and knee-replacement surgery (part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology. 2014;120(4):839–51.

    Article  CAS  Google Scholar 

  45. Detecting, managing and monitoring haemostasis: viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems). [https://www.nice.org.uk/guidance/dg13].

  46. Shah A, Roy NB, McKechnie S, Doree C, Fisher SA, Stanworth SJ. Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis. Crit Care. 2016;20(1):306.

    Article  Google Scholar 

  47. Diez-Lobo AI, Fisac-Martin MP, Bermejo-Aycar I, Munoz M. Preoperative intravenous iron administration corrects anemia and reduces transfusion requirement in women undergoing abdominal hysterectomy. Transf Alternat Transf Med. 2007;9:6.

    Article  Google Scholar 

  48. Litton E, Baker S, Erber WN, Farmer S, Ferrier J, French C, Gummer J, Hawkins D, Higgins A, Hofmann A, et al. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : a randomized trial of IV iron in critical illness. Intensive Care Med. 2016;42(11):1715–22.

    Article  CAS  Google Scholar 

  49. Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, An R, Bowers PJ, Burton P, Klausner MA, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med. 2007;357(10):965–76.

    Article  CAS  Google Scholar 

  50. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288(22):2827–35.

    Article  CAS  Google Scholar 

  51. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med. 1999;27(11):2346–50.

    Article  CAS  Google Scholar 

  52. Naidech AM, Kahn MJ, Soong W, Green D, Batjer HH, Bleck TP. Packed red blood cell transfusion causes greater hemoglobin rise at a lower starting hemoglobin in patients with subarachnoid hemorrhage. Neurocrit Care. 2008;9(2):198–203.

    Article  Google Scholar 

  53. Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma. 2008;65(4):951–60.

    Article  Google Scholar 

  54. Van Haren RM, Valle EJ, Thorson CM, Jouria JM, Busko AM, Guarch GA, Namias N, Livingstone AS, Proctor KG. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism. J Trauma Acute Care Surg. 2014;76(2):443–9.

    Article  Google Scholar 

  55. Larsson A, Greig-Pylypczuk R, Huisman A. The state of point-of-care testing: a European perspective. Ups J Med Sci. 2015;120(1):1–10.

    Article  Google Scholar 

  56. Ryan RJ, Lindsell CJ, Hollander JE, O'Neil B, Jackson R, Schreiber D, Christenson R, Gibler WB. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial. Ann Emerg Med. 2009;53(3):321–8.

    Article  Google Scholar 

  57. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Crit Care. 2006;10(4):222.

    Article  Google Scholar 

  58. Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med. 2014;370(9):847–59.

    Article  CAS  Google Scholar 

  59. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28(6):1871–6.

    Article  CAS  Google Scholar 

  60. Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost. 2008;34(8):709–33.

    Article  CAS  Google Scholar 

  61. Bolliger D, Tanaka KA. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev. 2013;27(4):213–20.

    Article  Google Scholar 

  62. Gorlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology. 2011;115(6):1179–91.

    PubMed  Google Scholar 

  63. Levi M, Hunt BJ. A critical appraisal of point-of-care coagulation testing in critically ill patients. J Thrombosis Haemostasis: JTH. 2015;13(11):1960–7.

    Article  CAS  Google Scholar 

  64. Crow S, Conrad SA, Chaney-Rowell C, King JW. Microbial contamination of arterial infusions used for hemodynamic monitoring: a randomized trial of contamination with sampling through conventional stopcocks versus a novel closed system. Infect Control Hosp Epidemiol. 1989;10(12):557–61.

    Article  CAS  Google Scholar 

  65. Mukhopadhyay A, Yip HS, Prabhuswamy D, Chan YH, Phua J, Lim TK, Leong P. The use of a blood conservation device to reduce red blood cell transfusion requirements: a before and after study. Crit Care. 2010;14(1):R7.

    Article  Google Scholar 

  66. Gleason E, Grossman S, Campbell C. Minimizing diagnostic blood loss in critically ill patients. American J Crit Care: An Official Publication, American Association of Critical-Care Nurses. 1992;1(1):85–90.

    CAS  Google Scholar 

  67. Riessen R, Behmenburg M, Blumenstock G, Guenon D, Enkel S, Schafer R, Haap M, Simple A. “Blood-Saving Bundle” reduces diagnostic blood loss and the transfusion rate in mechanically ventilated patients. PLoS One. 2015;10(9):e0138879.

    Article  Google Scholar 

  68. Hayden SJ, Albert TJ, Watkins TR, Swenson ER. Anemia in critical illness: insights into etiology, consequences, and management. Am J Respir Crit Care Med. 2012;185(10):1049–57.

    Article  Google Scholar 

  69. Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf. 2012;11(4):635–42.

    Article  CAS  Google Scholar 

  70. Levi M, van der Poll T. Endothelial injury in sepsis. Intensive Care Med. 2013;39(10):1839–42.

    Article  Google Scholar 

  71. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med. 2002;30(4):753–6.

    Article  Google Scholar 

  72. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, Cipolle MD, Cohn CS, Fung MK, Grossman BJ, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205–13.

    Article  Google Scholar 

  73. Sadani DT, Urbaniak SJ, Bruce M, Tighe JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transf Med (Oxford, England). 2006;16(5):375–9.

    Article  CAS  Google Scholar 

  74. Sapatnekar S, Sharma G, Downes KA, Wiersma S, McGrath C, Yomtovian R. Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets. J Clin Apher. 2005;20(4):225–9.

    Article  Google Scholar 

  75. Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have “high-titer” anti-A/A,B: implications for transfusion policy. Transfusion. 2004;44(6):805–8.

    Article  CAS  Google Scholar 

  76. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion. 2004;44(8):1143–8.

    Article  Google Scholar 

  77. Bilgin YM, van de Watering LM, Versteegh MI, van Oers MH, Vamvakas EC, Brand A. Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery. Transfusion. 2011;51(12):2603–10.

    Article  Google Scholar 

  78. Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg. 2009;108(4):1083–91.

    Article  Google Scholar 

  79. Rogers MA, Blumberg N, Heal JM, Hicks GL Jr. Increased risk of infection and mortality in women after cardiac surgery related to allogeneic blood transfusion. J Womens Health (Larchmt). 2007;16(10):1412–20.

    Article  Google Scholar 

  80. Brecher ME, Means N, Jere CS, Heath D, Rothenberg S, Stutzman LC. Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms. Transfusion. 2001;41(4):477–82.

    Article  CAS  Google Scholar 

  81. Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res. 2009;45(2–3):251–60.

    Article  CAS  Google Scholar 

  82. Aubron C, Flint AW, Bailey M, Pilcher D, Cheng AC, Hegarty C, Martinelli A, Reade MC, Bellomo R, McQuilten Z. Is platelet transfusion associated with hospital-acquired infections in critically ill patients? Crit Care. 2017;21(1):2.

    Article  Google Scholar 

  83. Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–58.

    Article  Google Scholar 

  84. Meybohm P, Herrmann E, Steinbicker AU, Wittmann M, Gruenewald M, Fischer D, Baumgarten G, Renner J, Van Aken HK, Weber CF, et al. Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for Patient’s outcome: a prospective, multicenter cohort study with a noninferiority design. Ann Surg. 2016;264(2):203–11.

    Article  Google Scholar 

  85. Gani F, Cerullo M, Ejaz A, Gupta PB, Demario VM, Johnston FM, Frank SM, Pawlik TM. Implementation of a blood management program at a tertiary care hospital: effect on transfusion practices and clinical outcomes among patients undergoing surgery. Ann Surg. 2017.

    Google Scholar 

Download references

Conflict of Interest

PM and KZ received grants by B. Braun Melsungen, CSL Behring, Fresenius Kabi and Vifor Pharma for the implementation of Frankfurt’s Patient Blood Management Program; honoraria for scientific lectures from B. Braun Melsungen, Vifor Pharma, Ferring, CSL Behring and Pharmacosmos. All other authors have no conflicts.

Funding Sources

This work did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick Meybohm MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Choorapoikayil, S., Zacharowski, K., Füllenbach, C., Meybohm, P. (2018). Patient Blood Management in Critically Ill. In: Shander, A., Corwin, H. (eds) Hematologic Challenges in the Critically Ill. Springer, Cham. https://doi.org/10.1007/978-3-319-93572-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93572-0_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-93571-3

  • Online ISBN: 978-3-319-93572-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics